The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 14, 2022

Filed:

Oct. 02, 2015
Applicant:

Cedars-sinai Medical Center, Los Angeles, CA (US);

Inventors:

Eduardo Marban, Santa Monica, CA (US);

Mark Amin Aminzadeh, Los Angeles, CA (US);

Assignee:

Cedars-Sinai Medical Center, Los Angeles, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/34 (2015.01); A61K 9/00 (2006.01); A61P 21/00 (2006.01); A61P 9/10 (2006.01); A61K 31/713 (2006.01); A61K 38/17 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 35/34 (2013.01); A61K 9/0019 (2013.01); A61K 31/713 (2013.01); A61K 38/1709 (2013.01); A61P 9/10 (2018.01); A61P 21/00 (2018.01); C12N 15/113 (2013.01); C12N 2310/141 (2013.01); C12N 2320/31 (2013.01); C12N 2320/32 (2013.01);
Abstract

Described herein are compositions and techniques related to generation and therapeutic application of cardiosphere-derived cells (CDCs) and CDC-derived exosomes. These cells and their secreted vesicles contain a unique milieu of biological factors, including cytokines, growth factors, transcription factors, nucleic acids including non-coding nucleic acids such as microRNAs, that serve to initiate and promote many therapeutic effects. Exosomes and their 'cargo' contents, such as microRNAs can favorably modulate apoptosis, inflammation and fibrosis in the injured heart. Thus, CDC-derived exosomes represent a novel 'cell-free' therapeutic candidate for tissue repair.


Find Patent Forward Citations

Loading…